{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:23:34Z","timestamp":1788175414172,"version":"build-2803163510"},"reference-count":45,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The efficacy and safety of a novel redirected T-cell\u2013based adoptive immunotherapy targeting hTERT for patients with adult T-cell leukemia. hTERT-specific T-cell receptor gene-transduced CD8+ T cells lyse ATL cells, but not normal cells, both in vitro and in vivo.<\/jats:p>","DOI":"10.1182\/blood-2012-11-465971","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T07:50:56Z","timestamp":1367567456000},"page":"4894-4901","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":40,"title":["Development of a novel redirected T-cell\u2013based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia"],"prefix":"10.1182","volume":"121","author":[{"given":"Yukihiro","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"},{"name":"Department of Cell Growth and Tumor Regulation, Ehime University Proteo-Medicine Research Center, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Asai","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"},{"name":"Immune Therapy Program, Ontario Cancer Institute, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Immunology, Nagoya City University School of Medical Sciences, Aichi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Takara Bio Inc., Otsu, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Mineno","sequence":"additional","affiliation":[{"name":"Center for Cell and Gene Therapy, Takara Bio Inc., Otsu, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Kuzushima","sequence":"additional","affiliation":[{"name":"Divison of Immunology, Aichi Cancer Center, Nagoya, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shiku","sequence":"additional","affiliation":[{"name":"Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yasukawa","sequence":"additional","affiliation":[{"name":"Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan;"},{"name":"Department of Cell Growth and Tumor Regulation, Ehime University Proteo-Medicine Research Center, Toon, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111819585251400_B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases.","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"issue":"4","key":"2019111819585251400_B2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"2019111819585251400_B3","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111819585251400_B4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111819585251400_B5","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111819585251400_B6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/CJI.0b013e3181f3cbf4","article-title":"Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.","volume":"33","author":"Louis","year":"2010","journal-title":"J Immunother"},{"issue":"2","key":"2019111819585251400_B7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1532\/IJH97.07092","article-title":"Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.","volume":"86","author":"Kannagi","year":"2007","journal-title":"Int J Hematol"},{"issue":"Pt 8","key":"2019111819585251400_B8","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","article-title":"HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes.","volume":"90","author":"Suemori","year":"2009","journal-title":"J Gen Virol"},{"issue":"13","key":"2019111819585251400_B9","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2011-09-379982","article-title":"Cancer\/testis antigens are novel targets of immunotherapy for adult T-cell leukemia\/lymphoma.","volume":"119","author":"Nishikawa","year":"2012","journal-title":"Blood"},{"issue":"1-2","key":"2019111819585251400_B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10616-004-5132-2","article-title":"Telomerase as a tumor-associated antigen for cancer immunotherapy.","volume":"45","author":"Patel","year":"2004","journal-title":"Cytotechnology"},{"issue":"8","key":"2019111819585251400_B11","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood-2003-12-4251","article-title":"Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.","volume":"104","author":"Sinha-Datta","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111819585251400_B12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1349-7006.2008.00798.x","article-title":"Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells.","volume":"99","author":"Hara","year":"2008","journal-title":"Cancer Sci"},{"issue":"7","key":"2019111819585251400_B13","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1182\/blood-2008-01-134692","article-title":"Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells.","volume":"112","author":"Bellon","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111819585251400_B14","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00262-006-0145-7","article-title":"Telomerase peptide vaccination: a phase I\/II study in patients with non-small cell lung cancer.","volume":"55","author":"Brunsvig","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"2019111819585251400_B15","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.1158\/0008-5472.CAN-07-2765","article-title":"Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.","volume":"67","author":"Domchek","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"2019111819585251400_B16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00262-011-0991-9","article-title":"hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes.","volume":"60","author":"Suso","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2019111819585251400_B17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood-2010-08-299396","article-title":"Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.","volume":"117","author":"Rapoport","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111819585251400_B18","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood.V97.9.2903","article-title":"Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.","volume":"97","author":"Arai","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2019111819585251400_B19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.20139","article-title":"Interferon-\u03b3 differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes.","volume":"110","author":"Tajima","year":"2004","journal-title":"Int J Cancer"},{"issue":"10","key":"2019111819585251400_B20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/annonc\/mdq544","article-title":"Relapse of renal cell carcinoma with disappearance of HLA class I following hTERT peptide vaccination.","volume":"21","author":"Yasukawa","year":"2010","journal-title":"Ann Oncol"},{"issue":"9","key":"2019111819585251400_B21","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22536","article-title":"Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells.","volume":"120","author":"Yano","year":"2007","journal-title":"Int J Cancer"},{"issue":"3","key":"2019111819585251400_B22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111819585251400_B23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.","volume":"29","author":"Robbins","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111819585251400_B24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med"},{"issue":"95","key":"2019111819585251400_B25","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med"},{"issue":"23","key":"2019111819585251400_B26","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-09-1450","article-title":"Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.","volume":"69","author":"Okamoto","year":"2009","journal-title":"Cancer Res"},{"key":"2019111819585251400_B27","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1038\/mtna.2012.52","article-title":"A promising vector for TCR gene therapy: Differential effect of siRNA, 2A peptide, and disulfide bond on the introduced TCR expression.","volume":"1","author":"Okamoto","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2019111819585251400_B28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-4608(88)90171-9","article-title":"Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells.","volume":"34","author":"Naoe","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"2019111819585251400_B29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.2910520316","article-title":"Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines.","volume":"52","author":"Fukudome","year":"1992","journal-title":"Int J Cancer"},{"issue":"2","key":"2019111819585251400_B30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.2910340213","article-title":"Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.","volume":"34","author":"Sugamura","year":"1984","journal-title":"Int J Cancer"},{"issue":"5","key":"2019111819585251400_B31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.161.5.1243","article-title":"Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus.","volume":"161","author":"Sugamura","year":"1985","journal-title":"J Exp Med"},{"issue":"5843","key":"2019111819585251400_B32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","article-title":"Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.","volume":"294","author":"Miyoshi","year":"1981","journal-title":"Nature"},{"issue":"4713","key":"2019111819585251400_B33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.2992081","article-title":"Infection of HTLV-III\/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.","volume":"229","author":"Harada","year":"1985","journal-title":"Science"},{"issue":"6","key":"2019111819585251400_B34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2011-02-337089","article-title":"Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.","volume":"118","author":"Ochi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111819585251400_B35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/blood-2008-06-164889","article-title":"Aurora-A kinase: a novel target of cellular immunotherapy for leukemia.","volume":"113","author":"Ochi","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111819585251400_B36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2011-06-360354","article-title":"Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity.","volume":"119","author":"Nagai","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2019111819585251400_B37","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"2019111819585251400_B38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-4-92","article-title":"HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).","volume":"4","author":"Kuhlmann","year":"2007","journal-title":"Retrovirology"},{"issue":"5","key":"2019111819585251400_B39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.","volume":"16","author":"Bendle","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"2019111819585251400_B40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/med.20211","article-title":"Telomere\/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications.","volume":"32","author":"Dolcetti","year":"2012","journal-title":"Med Res Rev"},{"issue":"6","key":"2019111819585251400_B41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1517\/14712598.2011.566853","article-title":"Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer.","volume":"11","author":"Ochi","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"2019111819585251400_B42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-6143.2012.04286.x","article-title":"Cord blood T cells retain early differentiation phenotype suitable for immunotherapy after TCR gene transfer to confer EBV specificity.","volume":"13","author":"Frumento","year":"2013","journal-title":"Am J Transplant"},{"issue":"8","key":"2019111819585251400_B43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019111819585251400_B44","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-11-1156","article-title":"Targeting regulatory T cells in cancer.","volume":"71","author":"Byrne","year":"2011","journal-title":"Cancer Res"},{"issue":"6","key":"2019111819585251400_B45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.","volume":"194","author":"Iellem","year":"2001","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/24\/4894\/1366523\/4894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/24\/4894\/1366523\/4894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:06:15Z","timestamp":1574125575000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/24\/4894\/31637\/Development-of-a-novel-redirected-Tcellbased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,13]]},"references-count":45,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2013,6,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-11-465971","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,13]]}}}